Stone House Investment Management, LLC
Position in CTKB — Cytek Biosciences, Inc.
CIK 1696497
TUNKHANNOCK, PA
Position in CTKB
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$1,389
New position
Shares Held
318
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Stone House Investment Management, LLC holds $87,217 across 15 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
638 | $57,892 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
182 | $11,649 | |
| 3 | MDT |
Medtronic plc
|
63 | $4,928 | |
| 4 | SYK |
Stryker Corp
|
11 | $3,463 | |
| 5 | NVCR |
NovoCure Ltd
|
191 | $2,893 | |
| 6 | BWAY |
Brainsway Ltd.
|
131 | $2,031 | |
| 7 | PACB |
Pacific Biosciences Of California, Inc.
|
797 | $1,338 | |
| 8 | AXGN |
Axogen, Inc.
|
14 | $646 |
All Filings in CTKB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,389 | 318 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||